Apoptosis, a type of programmed cell death that plays a key role in both healthy and pathological conditions, releases extracellular vesicles such as apoptotic bodies and microvesicles, but exosome release due to apoptosis is not yet commonly accepted. Here, the reports demonstrating the presence of apoptotic exosomes and their roles in inflammation and immune responses are summarized, together with a general summary of apoptosis and extracellular vesicles. In conclusion, apoptosis is not just a 'silent' type of cell death but an active form of communication from dying cells to live cells through exosomes.
ObjectivesZZThe aim of this study was to examine the effect of depression, impulsivity, and resilience on smartphone addiction in university students.MethodsZZA total of 322 students from two universities in Seoul were enrolled in this study. Participants were divided into a risk user group and normal user group according to results using the Korean smartphone addiction scale. We additionally surveyed smartphone use patterns of the participants. The Beck Depression Inventory (BDI), Barratt Impulsiveness Scale (BIS), and Conner-Davidson Resilience Scale (CD-RS) were also used for measurement of the participants' severity of depression, impulsivity, and resilience.ResultsZZThe risk user group spent more time using a smartphone on weekdays than the normal user group. The risk user group showed significantly higher scores on BDI, BIS than the normal user group. The risk user group showed significantly lower scores on CD-RS than the normal user group. Results of multiple regression analysis showed that impulsivity was a significant factor affecting smartphone addiction in university students.ConclusionZZThese results suggest that smartphone addiction is influenced by impulsivity. Students with high impulsivity may be vulnerable to smartphone addiction. Further research regarding the underlying mechanisms of these associations is needed.J Korean Neuropsychiatr Assoc 2014;53(4):214-220 KEY WORDSZZ Smartphone · Addiction · Impulsivity · Depression · Resilience.
The newly emerged coronavirus disease 19 , is threatening the world. Olfactory or gustatory dysfunction is reported as one of the symptoms worldwide. As reported so far, different clinical features have been reported according to outbreak sites and gender; most of the patients, who complained of anosmia or hyposmia, were Europeans. We had a fast review for novel articles about COVID-19 infection and olfactory function.Observations: Rapid reviews for COVID-19 or other viral infection and olfactory and/or gustatory dysfunctions were done in this review. Up to date, a lot of reports have shown that olfactory dysfunction is related to viral infections but no exact mechanism, clinical course, and definite treatment have been discovered, which is also same in COVID-19. In general, intranasal steroid (INS) and oral steroid for short time help improve the recovery of the olfactory function in case of olfactory dysfunction after virus infection. Considering severe respiratory complications and immunocompromised state of COVID-19, the use of steroid should be limited and cautious because we do not have enough data to support the usage of steroid to treat olfactory dysfunction in the clinical course of COVID-19.
Conclusions and relevance:In the days of pandemic COVID-19, we should keep in mind that olfactory dysfunctions, even without other upper respiratory infection or otolaryngologic symptoms, might be the early signs of COVID-19.
FC was strongly associated with disease activity indices, serologic markers, and endoscopic activity in patients with IBD. QPOCT can be used more conveniently than ELISA to assess FC in clinical practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.